Martine Rothblatt, United Therapeutics CEO, sells $4.66M in shares
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), sold $4.66 million worth of shares on November 4, 2026. She disposed of 7,748 shares, priced between $580.70 and $609.09 per share. The transactions were executed under a pre-approved 10b5-1 plan, and Rothblatt now owns 326,166 shares indirectly through a trust, along with 90,910 options held indirectly.
United Therapeutics' strong cash position, 86% gross profit margin, and robust product demand led to record third-quarter revenue of $832.5 million, even though earnings per share fell short of estimates.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Arhaus CEO John Reed sells $1.86 million in shares investing.com
